Support: 888-992-3836
|
NewsWire
|
Home
|
Login / Register
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
Hot!
Breakout Boards
Follow Feed
iHub My Stocks Activity
Ticker Buzz Cloud
Most Read
Most Posted
Most Followed Members
Recent News
News By Market
Active Boards
Site Stats
New Boards
Cannabis Stocks
Top PlusOneCoin Posters
Tools
Data Tools >
Charts
Trader Alerts
Trades
Portfolio
Top Lists
Price & News Alerts
Commodities
NewsWire
More Tools >
Newsletters
InvestorsHub Daily
My Image Gallery
Advanced Search
Videos
All News
Stock Screener
News Filter
Live Charts
Live News
Live Desktop
Forex Prices
Commodities
ETF Center
Educational Channel
Follow Feed
News Scanner
Crypto
Top Cryptocurrencies
PLUS1 Info & Faucet
Top Tokens
New Cryptocurrencies
Mining Profit Calculator
Crypto Converter
Streamer
Level 2
Home
>
Boards
>
US Listed
>
Biotechs
>
Otonomy, Inc. (OTIC)
Add OTIC Price Alert
Hide Sticky
Hide Intro
Moderator:
Search This Board:
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
Last Post:
2/22/2021 7:49:35 AM
-
Followers:
24
- Board type:
Free
- Posts Today:
0
Otonomy, Inc (OTIC)
Company website
Company Address:
6275 Nancy Ridge Drive
Suite 100
San Diego, CA 92121
United States -
Map
Phone: 858-242-5200
Fax: 858-200-0933
Otonomy, Inc.
is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of diseases and disorders of the ear. To overcome many of the limitations of delivering drugs to the middle and inner ear, we have developed a proprietary technology that is designed to deliver drug that is retained in the ear for an extended period of time following a single local administration, which we refer to as “sustained-exposure.” Utilizing this technology, we have advanced three product candidates into development: AuriPro, OTO-104 and OTO-311. Our lead product candidate, AuriPro, is a sustained-exposure antibiotic that has completed two identical Phase 3 clinical trials in a total of 532 pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. Top-line results of these Phase 3 trials demonstrated that AuriPro achieved the primary efficacy endpoint with statistical significance (p<0.001) and was well tolerated. Our second product candidate, OTO-104, is a sustained-exposure steroid in a Phase 2b clinical trial for patients with Ménière’s disease. Our third product candidate, OTO-311, is in preclinical development as a treatment for tinnitus. There are no drugs approved by the FDA for the lead indications we are currently pursuing for our product candidates.
Management
Pipeline
Yahoo Headlines
Seeking Alpha
Press Releases
SEC Filings
Share Structure:
See SEC filings
Investor Relations:
ir@otonomy.com
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.
Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp
OTIC
Current Price
Volume:
Bid
Ask
Day's Range
OTIC Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
OTIC News: Otonomy to Participate in Three Upcoming Investor Conferences
02/25/2021 07:30:00 AM
OTIC News: Otonomy sinks after Otividex fails in late-stage trial for Ménière’s disease
02/22/2021 07:53:50 AM
OTIC News: Current Report Filing (8-k)
02/22/2021 07:17:45 AM
OTIC News: Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease
02/22/2021 07:00:00 AM
OTIC News: Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
02/17/2021 07:30:00 AM
Post New Msg
Follow Board
My Stocks (18)
Hide Intro
View Posters
OTIC Poststream
Bans (0)
Hide Quote
Filter Disabled
Post
Subject
#432
Otonomy Announces Top-Line Results for the Phase 3
realfast95
02/22/21 07:49:35 AM
#431
I reduced my holdings a few months ago.
Cody6
12/20/20 11:43:34 AM
#430
Yea still holding and will be for a
Sadie115
12/14/20 08:47:07 AM
#429
Sadie, are you still holding $OTIC? Any thoughts
Cody6
12/12/20 07:21:16 PM
#428
Billionaire Steven Cohen Pulls the Trigger on These
stockguard
08/17/20 06:27:12 PM
#427
Well this is on a wild ride today.
Sadie115
07/14/20 12:12:20 PM
#426
OTIC 3.92 Otonomy Inc
er111a
07/06/20 06:20:42 PM
#425
Pretty impressive run happening. Hope it continues. Does
Cody6
12/30/19 11:35:09 AM
#424
$2.72 now, wow
wesley_
03/11/19 06:58:13 PM
#423
yeah nice volume
wesley_
03/05/19 12:23:09 PM
#422
$OTIC looking strong!
Cody6
03/05/19 12:04:50 PM
#421
There’s a $3.60 spread between the bid and
Cody6
06/05/18 01:45:30 AM
#420
Much easier. Drugs already approved just a different
Sadie115
02/10/18 04:40:23 PM
#419
this is an sNDA right? if so, any1
tenesea
02/09/18 04:33:03 PM
#418
Appears that Blackrock distributed its $OTIC stock holdings
Cody6
01/30/18 12:02:27 AM
#417
Hi. Is FDA approval imminent? Is price target
J_Dean
01/26/18 01:00:20 PM
#416
Shhh, this board is very quiet. Shareholders sleeping.
Cody6
01/23/18 08:55:23 PM
#415
OTIC news AH- https://ih.advfn.com/p.php?pid=nmona&article=76525067&symbol=OTIC
AOuvier
01/23/18 08:54:45 AM
#414
I wonder what you’re doing $OTIC? Consolidating for
Cody6
01/21/18 11:06:38 PM
#413
OTIC 6.20
AOuvier
01/12/18 10:44:46 AM
#412
well $OTIC tomorrow 6 good for me 2 $$$$$$$$$$
Blade$dream
01/02/18 04:24:50 PM
#411
Well going over $6...today? I hope so.... ;-)
Blade$dream
01/02/18 06:20:47 AM
#410
$OTIC looking strong today!
Cody6
12/29/17 10:34:43 AM
#409
OTIC- https://ih.advfn.com/p.php?pid=nmona&article=76339735&symbol=OTIC
AOuvier
12/21/17 09:03:27 AM
#408
Now back to enjoy my rest of Christmas vaca.....
Blade$dream
12/21/17 06:09:39 AM
#407
Man I like my $OTIC & $NOG ;-)
Blade$dream
12/21/17 06:08:55 AM
#406
Don't sell $OTIC ;-)
Blade$dream
11/27/17 10:18:03 PM
#405
Hang in there @sadie115. I have a feeling
Cody6
11/21/17 08:48:01 AM
#404
Once in a wile I will check in
Blade$dream
11/16/17 11:59:20 AM
#403
Well it didn't get as high as I
Sadie115
11/11/17 10:03:56 AM
#402
$OTIC back on track....glad I didn't sold :-)
Blade$dream
11/10/17 02:07:08 PM
#401
$OTIC Looks like its holding sort off from
Blade$dream
11/10/17 08:17:03 AM
#400
I did not sell because of my job...overworked
Blade$dream
11/10/17 02:33:51 AM
#398
That was from Sept 2 months late but correct!
cjstocksup
11/09/17 02:58:39 PM
#397
l2 hunter Member Level Friday, 09/08/17 10:41:28 AM
l2 hunter
11/09/17 01:28:34 PM
#396
GL covering ahead. Better do it during market
cjstocksup
11/09/17 12:50:02 PM
#395
Given I shorted in premarket good luck. Just
rusty8350
11/09/17 12:48:51 PM
#394
GL shorting OTIC you will get crushed! Institutions
cjstocksup
11/09/17 12:45:07 PM
#393
I agree. OTIC should be back at least
cjstocksup
11/09/17 12:40:25 PM
#392
This stock has over 30 million shares outstanding
rusty8350
11/09/17 12:30:24 PM
#391
OTIC hit $7.50 during after hours trading last
SchlumpyStock-Picker
11/09/17 11:39:37 AM
#390
OTIC was at almost $7.00 premarket she should
cjstocksup
11/09/17 11:33:05 AM
#389
C'mon 6.
MMMQA
11/09/17 10:45:26 AM
#388
Back Home... loaded and ready for 7,50+
europtiger
11/09/17 10:35:45 AM
#387
We go up now!! The beast is roaring!! OTIC
Lone Wolf
11/09/17 10:33:55 AM
#386
This is a beast right now.
MMMQA
11/09/17 10:30:54 AM
#385
Hey I'm just back from a meeting at
Blade$dream
11/09/17 10:26:01 AM
#384
Just 30 minutes into the trading day and
SchlumpyStock-Picker
11/09/17 10:07:46 AM
#383
those 80% Inst owns, will run this
[SMART MONEY]
11/09/17 09:59:55 AM
#382
MONSTA TRADING VOLUME!!! OTIC ROCK'N ROLL
l2 hunter
11/09/17 09:53:49 AM
Post
Subject
Post New Msg
Follow Board
My Stocks (18)
Hide Intro
View Posters
OTIC Poststream
Bans (0)
Hide Quote
Filter Disabled
Balance Available:
0
Get FREE PlusOneCoins!
© 2021 InvestorsHub.com, Inc.
Consent Preferences